Vetpa - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 28,020 | 26,813 | 26,262 | 27,017 | 29,742 | 32,106 | 35,541 | 26,011 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -1,982 | -2,029 | -1,961 | -1,154 | 1,932 | -1,428 | -720 | -4,135 |
| Equity | 102 | -1,927 | -3,888 | -5,042 | -3,110 | -4,538 | -5,258 | -9,393 |
| Liabilities | 3,250 | 3,539 | 5,842 | 5,338 | 3,697 | 4,927 | 5,407 | 9,393 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 3,352 | 1,612 | 1,954 | 296 | 587 | 389 | 149 | 0 |
| Total assets | 3,352 | 1,612 | 1,954 | 296 | 587 | 389 | 149 | 0 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 2,626 | 3,118 | 3,081 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -5.6% | -4.3% | -2.1% | +2.9% | +10.1% | +7.9% | +10.7% | -26.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -59.1% | -125.9% | -100.4% | -389.9% | 329.1% | -367.1% | -483.2% | - |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -1943.1% | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -7.1% | -7.6% | -7.5% | -4.3% | 6.5% | -4.4% | -2.0% | -15.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 31.9 | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 14,010 | 13,407 | 13,131 | 13,509 | 14,871 | 16,053 | 17,771 | 13,006 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vetpa - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-09-18 | 2023-10-15 | 0.51 |
| 2023-08-17 | 2023-09-13 | 0.51 |
| 2023-07-24 | 2023-08-13 | 0.51 |
| 2023-04-18 | 2023-04-23 | 245.13 |
Vetpa - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-11-02 | 2025-11-02 | 0.08 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vetpa, UAB (code 173212877) is a private limited liability company operating in the retail sale of pharmaceutical products. In 2025, the latest financial year, revenue declined to €26.0K, down 26.8% year on year and 19.0% over two years. The company posted a net loss of €4.1K, compared with a loss of €720 in 2024 and €1.4K in 2023, so profitability weakened after a brief improvement in 2024. The 2025 profit margin was -15.9%. The three-year revenue trend shows an increase from €32.1K in 2023 to €35.5K in 2024, followed by a sharper contraction in 2025. The balance sheet remained under pressure: equity was negative at -€9.4K in 2025, while liabilities were €9.4K. Available prior-year figures show total assets of €149 in 2024, with equity of -€5.3K and liabilities of €5.4K. Revenue per employee was €13.0K, while profit per employee was -€2.1K.